0001209191-23-019944.txt : 20230317 0001209191-23-019944.hdr.sgml : 20230317 20230317210010 ACCESSION NUMBER: 0001209191-23-019944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230315 FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Owens Daniel E. CENTRAL INDEX KEY: 0001858105 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 23744712 MAIL ADDRESS: STREET 1: C/O TREACE MEDICAL CONCEPTS, INC. STREET 2: 203 FORT WADE ROAD, SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-15 1 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001858105 Owens Daniel E. C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 0 0 0 1 Chief Human Resources Officer Common Stock 2023-03-15 4 M 0 6250 7.028 A 37164 D Common Stock 2023-03-15 4 S 0 6250 22.8729 D 30914 D Stock Option Right to Buy 7.028 2023-03-15 4 M 0 6250 0.00 D 2031-02-02 Stock Option Right to Buy 6250 176375 D The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Includes 25,650 RSUs. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. Lisa Taylor as Attorney-in-fact for Dan Owens 2023-03-17